This inventor holds 1 USPTO granted patent. Top assignee: University of Cincinnati. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Innovations by Steve Davidson in Opioid Reversal
Introduction
Steve Davidson is an accomplished inventor based in Cincinnati, OH (US). He has made significant contributions to the field of medicine, particularly in the area of opioid overdose treatment. His innovative approach focuses on developing long-lasting opioid reversal agents that can effectively respond to overdose situations.
Latest Patents
Davidson holds a patent for a groundbreaking formulation titled "Long lasting opioid reversal using hydrogen peroxide-induced release in blood." This patent discloses Naloxone variants that are both long-lasting and responsive. One version of the compound features a boron ester functional group, allowing for a sustained release of the antagonist based on its reaction with hydrogen peroxide. The patent also outlines a method for treating opioid overdose, which involves administering a therapeutically effective amount of the formulation to a patient in need. The administration can occur intranasally, sublingually, or through a combination of both methods, ensuring flexibility in treatment options.
Career Highlights
Davidson's career is marked by his dedication to advancing medical science and improving patient outcomes. His work at the University of Cincinnati has positioned him as a key figure in the research community, where he continues to explore innovative solutions to pressing health issues.
Collaborations
Davidson collaborates with Priyangika Senevirathne, contributing to the development of new therapeutic strategies and enhancing the impact of their research.
Conclusion
Steve Davidson's innovative work in opioid reversal represents a significant advancement in medical treatment. His patent and ongoing research efforts highlight the importance of developing effective solutions to combat the opioid crisis.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
